BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 36611858)

  • 1. Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma.
    Zhang Y; Zhuang T; Xin Z; Sun C; Li D; Ma N; Wang X; Wang X
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.
    Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M
    Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel necroptosis-related long noncoding RNA model for predicting clinical features, immune characteristics, and therapeutic response in clear cell renal cell carcinoma.
    Zhang L; Chen Y; Hu W; Wu B; Ye L; Wang D; Bai T
    Front Immunol; 2023; 14():1230267. PubMed ID: 37600792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature.
    Chen W; Lin W; Wu L; Xu A; Liu C; Huang P
    Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523
    [No Abstract]   [Full Text] [Related]  

  • 5. Establishment of a novel signature to predict prognosis and immune characteristics of pancreatic cancer based on necroptosis-related long non-coding RNA.
    Xiong Y; Kong X; Fang K; Sun G; Tu S; Wei Y; Ouyang Y; Wan R; Xiao W
    Mol Biol Rep; 2023 Sep; 50(9):7405-7419. PubMed ID: 37452900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
    Yu J; Mao W; Xu B; Chen M
    Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma.
    Zhang W; Liu Z; Wang J; Geng B; Hou W; Zhao E; Li X
    Front Immunol; 2022; 13():934387. PubMed ID: 35958561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel necroptosis-related lncRNA signature for predicting prognosis and anti-cancer treatment response in endometrial cancer.
    He WP; Chen YY; Wu LX; Guo YY; You ZS; Yang GF
    Front Immunol; 2022; 13():1018544. PubMed ID: 36466815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of necroptosis-related lncRNA signature with potential implications in tumor heterogeneity and prediction of prognosis in clear cell renal cell carcinoma.
    Lin H; Qu L; Chen G; Zhang C; Lu L; Chen Y
    Eur J Med Res; 2023 Jul; 28(1):236. PubMed ID: 37452355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene set enrichment analysis identifies immune subtypes of kidney renal clear cell carcinoma with significantly different molecular and clinical properties.
    Chen Z; Cao W; Luo J; Abdelrahman Z; Lu Q; Wang H; Wang X
    Front Immunol; 2023; 14():1191365. PubMed ID: 37426638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Validation of a Necroptosis-Related Prognostic Signature for Kidney Renal Clear Cell Carcinoma.
    Cai M; Yang Q; He J; Wu H; Li Z; Fang Z; Li J
    Stem Cells Int; 2023; 2023():8446765. PubMed ID: 36910333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A risk signature based on necroptotic-process-related genes predicts prognosis and immune therapy response in kidney cell carcinoma.
    Li J; Liu X; Qi Y; Liu Y; Du E; Zhang Z
    Front Immunol; 2022; 13():922929. PubMed ID: 36189275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma.
    Khadirnaikar S; Kumar P; Pandi SN; Malik R; Dhanasekaran SM; Shukla SK
    Mol Carcinog; 2019 Apr; 58(4):544-553. PubMed ID: 30520148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis Signature of Cuprotosis-Related lncRNAs Associated with Kidney Renal Clear Cell Carcinoma.
    Gao Y; Jia Z
    Genet Res (Camb); 2022; 2022():6004852. PubMed ID: 36474620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A risk signature of necroptosis-related lncRNA to predict prognosis and probe molecular characteristics for male with bladder cancer.
    Jin Y; Li J; Tang C; He K; Shan D; Yan S; Deng G
    Medicine (Baltimore); 2023 May; 102(18):e33664. PubMed ID: 37145007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma.
    Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M
    Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of necroptosis-related long noncoding RNA to predict prognosis, immune status, and immunotherapeutic response in clear cell renal cell carcinoma.
    Tang H; Chen H; Yuan H; Jin X; Chen G
    Transl Cancer Res; 2022 Dec; 11(12):4254-4271. PubMed ID: 36644185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive prognostic and immunological analysis of telomere-related lncRNAs in kidney renal clear cell carcinoma.
    Chen J; Zhang D; Ren X; Wang P
    Aging (Albany NY); 2023 Oct; 15(20):11012-11032. PubMed ID: 37847171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of N6-Methyladenosine-Related IncRNAs Prognostic Signature and the Associated Immune Infiltrates in Kidney Renal Clear Cell Carcinoma.
    Chen X; Wang L; Tu J; Pan X; Li Y; Yin H; Wang M; Yuan X
    Crit Rev Eukaryot Gene Expr; 2022; 32(1):79-98. PubMed ID: 35377983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.